NeuroMetrix's Strategic Review Sets Path for Neurological Innovation and Growth
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder ValueWOBURN, Mass., Feb. 13, 2024 - NeuroMetrix, Inc. (Nasdaq: NURO), a leading medical device company specializing in reducin...
Feb 13, 2024
• Medical Equipment & Supplies Industry
Product Service News
NeuroMetrix